Targeting senescent cells: approaches, opportunities, challenges
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a hallmark of aging, whose onset is linked to a series of both cell and non-cell autonomous processes, leading to several consequences for the organism. To date, several senescence routes have been identified, which play a fundamental role in development, tumor suppression and aging, among other processes. The positive and/or negative effects of senescent cells are directly related to the time that they remain in the organism. Short-term (acute) senescent cells are associated with positive effects; once they have executed their actions, immune cells are recruited to remove them. In contrast, long-term (chronic) senescent cells are associated with disease; they secrete pro-inflammatory and pro-tumorigenic factors in a state known as senescence-associated secretory phenotype (SASP). In recent years, cellular senescence has become the center of attention for the treatment of aging-related diseases. Current therapies are focused on elimination of senescent cell functions in three main ways: i) use of senolytics; ii) inhibition of SASP; and iii) improvement of immune system functions against senescent cells (immunosurveillance). In addition, some anti-cancer therapies are based on the induction of senescence in tumor cells. However, these senescent-like cancer cells must be subsequently cleared to avoid a chronic pro-tumorigenic state. Here is a summary of different scenarios, depending on the therapy used, with a discussion of the pros and cons of each scenario.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“First described in cultured human diploid fibroblasts after successive rounds of division [2], its main hallmarks are irreversible growth arrest, alterations of cell size and morphology, increased lysosomal activity, expression of anti-proliferative proteins, resistance to apoptosis, activation of damagesensing signal…”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 1×
“The role of the immune system in the elimination of senescent cells is fundamental, and a decline in immune function is associated with an increase in the number of senescent cells and finally, disease (Figure 4, step 4) [12, 20, 79, 80].”
BackgroundThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 2×
“Dasatinib (D) Inhibitor EFNB*-dependent suppression of apoptosis [51]”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“com 12845 AGING cancer stop tumor growth while causing accumulation of senescent cells [13, 14], which subsequently become a problem for the organism [15].”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Research works printed but not linked: 40
- Kirkland, 2017, Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice., J Gerontol A Biol Sci Med Sci, 7, 780, 10.1093/gerona/glw154 · DOI · Paper page
- Maier, 2012, The number of p16INK4a positive cells in human skin reflects biological age., Aging Cell, 1, 722, 10.1111/j.1474-9726.2012.00837.x · DOI · Paper page
- Demaria, 2016, Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-Review., Gerontology, 6, 513, 10.1159/000444877 · DOI · Paper page
- von Kobbe, 2018, Cellular senescence: a view throughout organismal life., Cell Mol Life Sci, 7, 3553, 10.1007/s00018-018-2879-8 · DOI
- Demaria, 2018, Hallmarks of Cellular Senescence., Trends Cell Biol, 2, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- Chen, 2008, DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence., J Biol Chem, 28, 2896, 10.1074/jbc.m708624200 · DOI
- Morrison, 2009, Mechanisms of stem cell self-renewal., Annu Rev Cell Dev Biol, 2, 377, 10.1146/annurev.cellbio.042308.113248 · DOI · Paper page
- von Zglinicki, 2019, The bystander effect contributes to the accumulation of senescent cells in vivo., Aging Cell, 1, e12848, 10.1111/acel.12848 · DOI · Paper page
- LeBrasseur, 2018, Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations., Curr Rheumatol Rep, 2, 3, 10.1007/s11926-018-0712-x · DOI
- de Magalhães, 2013, How ageing processes influence cancer., Nat Rev Cancer, 1, 357, 10.1038/nrc3497 · DOI · Paper page
- van Deursen, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis., Science, 35, 472, 10.1126/science.aaf6659 · DOI · Paper page
- Homma, 2015, Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice., PLoS One, 1, e0124129, 10.1371/journal.pone.0124129 · DOI
- McKeegan, 2012, Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer., Clin Cancer Res, 1, 3163, 10.1158/1078-0432.CCR-11-3090 · DOI · Paper page
- Alimonti, 2016, Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer., Trends Cell Biol, 2, 215, 10.1016/j.tcb.2015.10.005 · DOI
- van der Meer, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases., Nat Rev Drug Discov, 1, 633, 10.1038/nrd3800 · DOI · Paper page
- Donath, 2015, Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus., J Diabetes Complications, 2, 955, 10.1016/j.jdiacomp.2015.05.019 · DOI
- Burotto, 2017, MABp1 for the treatment of colorectal cancer., Expert Opin Biol Ther, 1, 1155, 10.1080/14712598.2017.1347631 · DOI
- Wilson, 2008, The interleukin-8 pathway in cancer., Clin Cancer Res, 1, 6735, 10.1158/1078-0432.CCR-07-4843 · DOI · Paper page
- Soth, 2010, Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders., J Med Chem, 5, 2345, 10.1021/jm9012906 · DOI · Paper page
- Giovannelli, 2013, Chronic resveratrol treatment ameliorates cell adhesion and mitigates the inflammatory phenotype in senescent human fibroblasts., J Gerontol A Biol Sci Med Sci, 6, 371, 10.1093/gerona/gls183 · DOI · Paper page
- Baldwin, 2000, Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase., Cancer Res, 6, 3477
- Chiu, 2019, Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis., Cell Metab, 2, 335, 10.1016/j.cmet.2018.09.019 · DOI · Paper page
- Nonell-Canals, 2018, Metformin directly targets the H3K27me3 demethylase KDM6A/UTX., Aging Cell, 1, e12772, 10.1111/acel.12772 · DOI · Paper page
- Klubo-Gwiezdzinska, 2018, Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancerand, Clin Cancer Res, 2, 4030, 10.1158/1078-0432.CCR-17-3167 · DOI
- Carling, 2002, The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways., J Biol Chem, 27, 25226, 10.1074/jbc.M202489200 · DOI · Paper page
- Franceschi, 2014, Lamins are rapamycin targets that impact human longevity: a study in centenarians., J Cell Sci, 12, 147, 10.1242/jcs.133983 · DOI
- Wolf, 2016, The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK., Leukemia, 3, 2119, 10.1038/leu.2016.155 · DOI
- Lawson, 2014, Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling., MAbs, 6, 774, 10.4161/mabs.28612 · DOI
- Wu, 2017, Chimeric antigen receptor T cells: a novel therapy for solid tumors., J Hematol Oncol, 1, 78, 10.1186/s13045-017-0444-9 · DOI · Paper page
- von Kobbe, 2012, Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors., PLoS One, 7, e52976, 10.1371/journal.pone.0052976 · doi:10.1371/journal.pone.0052976
- Bachmann, 2006, A second vaccine revolution for the new epidemics of the 21st century., Drug Discov Today, 1, 1028, 10.1016/j.drudis.2006.09.006 · DOI
- Mavroudis, 2012, Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001., Cancer Immunol Immunother, 6, 157, 10.1007/s00262-011-1093-4 · DOI
- Sparwasser, 2016, Immunometabolism and autoimmunity., Immunol Cell Biol, 9, 925, 10.1038/icb.2016.77 · DOI
- Yang, 2019, Dysfunction of immune system in the development of large granular lymphocyte leukemia., Hematology, 2, 139, 10.1080/10245332.2018.1535294 · DOI
- Rodier, 2016, Premature aging/senescence in cancer cells facing therapy: good or bad?, Biogerontology, 1, 71, 10.1007/s10522-015-9593-9 · DOI
- Gewirtz, 2019, Tumor cell escape from therapy-induced senescence., Biochem Pharmacol, 16, 202, 10.1016/j.bcp.2018.12.013 · DOI · Paper page
- Department of Economic and Social Affairs (DESA), 2015, World population ageing.
- Yao, 2016, Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans: A case-control study., Medicine (Baltimore), 9, e3869, 10.1097/MD.0000000000003869 · DOI
- Minamino, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity., Cell Rep, 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
- Spector, 1995, Oxidative stress-induced cataract: mechanism of action., FASEB J, 9, 1173, 10.1096/fasebj.9.12.7672510 · DOI · Paper page
Cited by
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Secomandi, L., Borghesan, M., Velarde, M., & Demaria, M. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmab038 · Cited by 208
“Alternatively, neutralizing antibodies can be administered against individual SASP factors, such as IL1a, IL-8 and IL-6, for higher specificity (von Kobbe, 2019).”
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis
Soberanes, S., Misharin, A. V., Jairaman, A., Morales-Nebreda, L., McQuattie-Pimentel, A. C., Cho, T., Hamanaka, R. B., Meliton, A. Y., Reyfman, P. A., Walter, J. M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.019 · Cited by 131
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Rossi, M., & Abdelmohsen, K. (2021) · Cells · doi:10.3390/cells10071740 · Cited by 71
Metadata
- Authors
- von Kobbe, C.
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2019-11-30
- Volume
- 11
- Issue
- 24
- Pages
- 12844-12861
- ISSN
- 1945-4589 (ISSN-L)
- OpenAlex
- W2992558821
- Cited by
- 127
- References
- 70
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting senescent cells: approaches, opportunities, challenges. https://app.cochat.ai/papers/10.18632/aging.102557
- The paper
- von Kobbe, C. (2019). Targeting senescent cells: approaches, opportunities, challenges. Aging. https://doi.org/10.18632/aging.102557
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.